Anzeige
Mehr »
Freitag, 17.07.2026 - Börsentäglich über 12.000 News
Wenn nationale Sicherheit in den Vorstandsetagen ankommt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PH0N | ISIN: CA2524423068 | Ticker-Symbol: 4D4A
Frankfurt
16.07.26 | 08:11
0,149 Euro
-0,67 % -0,001
1-Jahres-Chart
DIAGNOS INC Chart 1 Jahr
5-Tage-Chart
DIAGNOS INC 5-Tage-Chart

Aktuelle News zur DIAGNOS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SaDiagnos Inc (3): Diagnos 6,715,369 warrants extended1
08.07.Diagnos Inc (3): Diagnos to extend expiry of 6.71M warrants to 20271
07.07.DIAGNOS Inc.: DIAGNOS to Extend the Exercise Period of Stock Warrants1
23.06.Diagnos Inc (3): Diagnos 625,000 shares for debt1
DIAGNOS Aktie jetzt für 0€ handeln
18.06.DIAGNOS Inc.: DIAGNOS Announces Shares for Debt Settlement244BROSSARD, Quebec, June 18, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related...
► Artikel lesen
16.06.DIAGNOS Inc.: DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform2
12.06.Diagnos Inc (3): Diagnos adopts semi-annual financial reporting1
12.06.DIAGNOS Inc.: DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting1
05.06.DIAGNOS Inc.: Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform1
20.05.Diagnos Inc (3): Diagnos convertible debenture amendment2
14.05.DIAGNOS Inc.: DIAGNOS Announces Amendment to Convertible Debentures1
23.04.Diagnos Inc (3): Diagnos 5,228,668 warrants extended1
09.04.Diagnos Inc (3): Diagnos talks regulatory progress for Cara1
08.04.DIAGNOS Inc.: DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA141BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related...
► Artikel lesen
02.04.Diagnos Inc (3): Diagnos completes medical device establishment renewal1
01.04.DIAGNOS Inc.: DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration218BROSSARD, Quebec, April 01, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of eye-related...
► Artikel lesen
31.03.Diagnos Inc (3): Diagnos replacement convertible debentures1
06.03.Diagnos Inc (3): Diagnos to amend convertible debenture, warrant terms1
05.03.DIAGNOS Inc.: DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants1
05.02.Diagnos Inc (3): Diagnos expects to receive $1M in federal investments1
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1